Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
GODAVARI DRU TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
GODAVARI DRU Mar-23 |
TEVA PHARMA Dec-13 |
GODAVARI DRU/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 102 | 3,479 | - | |
Low | Rs | 52 | 3,022 | - | |
Sales per share (Unadj.) | Rs | 212.0 | 1,996.4 | - | |
Earnings per share (Unadj.) | Rs | 5.0 | 124.7 | - | |
Cash flow per share (Unadj.) | Rs | 7.6 | 286.1 | - | |
Dividends per share (Unadj.) | Rs | 0 | 109.18 | - | |
Avg Dividend yield | % | 0 | 3.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 44.4 | 2,217.6 | - | |
Shares outstanding (eoy) | m | 7.53 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 1.6 | 22.3% | |
Avg P/E ratio | x | 15.3 | 26.1 | 58.8% | |
P/CF ratio (eoy) | x | 10.1 | 11.4 | 89.1% | |
Price / Book Value ratio | x | 1.7 | 1.5 | 118.4% | |
Dividend payout | % | 0 | 87.5 | 0.0% | |
Avg Mkt Cap | Rs m | 580 | 2,756,220 | 0.0% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 48 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,667.6 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,353.1 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,596 | 1,692,969 | 0.1% | |
Other income | Rs m | 7 | 0 | - | |
Total revenues | Rs m | 1,603 | 1,692,969 | 0.1% | |
Gross profit | Rs m | 102 | 463,620 | 0.0% | |
Depreciation | Rs m | 19 | 136,844 | 0.0% | |
Interest | Rs m | 39 | 33,253 | 0.1% | |
Profit before tax | Rs m | 49 | 293,523 | 0.0% | |
Minority Interest | Rs m | 0 | 1,333 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,682 | -0.0% | |
Tax | Rs m | 11 | -3,584 | -0.3% | |
Profit after tax | Rs m | 38 | 105,758 | 0.0% | |
Gross profit margin | % | 6.4 | 27.4 | 23.2% | |
Effective tax rate | % | 23.3 | -1.2 | -1,906.8% | |
Net profit margin | % | 2.4 | 6.2 | 38.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 870 | 1,143,425 | 0.1% | |
Current liabilities | Rs m | 737 | 997,163 | 0.1% | |
Net working cap to sales | % | 8.3 | 8.6 | 96.4% | |
Current ratio | x | 1.2 | 1.1 | 102.9% | |
Inventory Days | Days | 1 | 91 | 1.1% | |
Debtors Days | Days | 1,325 | 96 | 1,381.2% | |
Net fixed assets | Rs m | 344 | 552,961 | 0.1% | |
Share capital | Rs m | 75 | 4,167 | 1.8% | |
Net worth | Rs m | 334 | 1,880,567 | 0.0% | |
Long term debt | Rs m | 119 | 865,653 | 0.0% | |
Total assets | Rs m | 1,214 | 3,868,976 | 0.0% | |
Interest coverage | x | 2.3 | 9.8 | 23.0% | |
Debt to equity ratio | x | 0.4 | 0.5 | 77.7% | |
Sales to assets ratio | x | 1.3 | 0.4 | 300.4% | |
Return on assets | % | 6.4 | 3.6 | 176.8% | |
Return on equity | % | 11.3 | 5.6 | 201.4% | |
Return on capital | % | 19.5 | 4.9 | 396.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 132 | 269,772 | 0.0% | |
From Investments | Rs m | -86 | -95,591 | 0.1% | |
From Financial Activity | Rs m | -38 | -323,609 | 0.0% | |
Net Cashflow | Rs m | 8 | -149,429 | -0.0% |
Compare GODAVARI DRU With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare GODAVARI DRU With: DENIS CHEM LAB SYSCHEM (I). UNICHEM LAB BLISS GVS PHARMA GRANULES INDIA
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.